GPR35 (gpr35_human)
FAMILY
Class A (Rhodopsin) Orphan receptors Class A orphans GPR35
GENE
GPR35
ORGANISM
Human (Homo sapiens)
ALT. NAMES
G-protein coupled receptor 35, Kynurenic acid receptor, KYNA receptor
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
N
|
G
|
T
|
Y
|
N
|
T
|
C
|
G
|
S
|
10 |
TM1 | |||||||||
S
|
D
|
L
|
T
|
W
|
P
|
P
|
A
|
I
|
K
|
20 |
L
|
G
|
F
|
Y
|
A
|
Y
|
L
|
G
|
V
|
L
|
30 |
L
|
V
|
L
|
G
|
L
|
L
|
L
|
N
|
S
|
L
|
40 |
A
|
L
|
W
|
V
|
F
|
C
|
C
|
R
|
M
|
Q
|
50 |
ICL1 | TM2 | ||||||||
Q
|
W
|
T
|
E
|
T
|
R
|
I
|
Y
|
M
|
T
|
60 |
N
|
L
|
A
|
V
|
A
|
D
|
L
|
C
|
L
|
L
|
70 |
C
|
T
|
L
|
P
|
F
|
V
|
L
|
H
|
S
|
L
|
80 |
ECL1 | TM3 | ||||||||
R
|
D
|
T
|
S
|
D
|
T
|
P
|
L
|
C
|
Q
|
90 |
L
|
S
|
Q
|
G
|
I
|
Y
|
L
|
T
|
N
|
R
|
100 |
Y
|
M
|
S
|
I
|
S
|
L
|
V
|
T
|
A
|
I
|
110 |
A
|
V
|
D
|
R
|
Y
|
V
|
A
|
V
|
R
|
H
|
120 |
ICL2 | |||||||||
P
|
L
|
R
|
A
|
R
|
G
|
L
|
R
|
S
|
P
|
130 |
TM4 | |||||||||
R
|
Q
|
A
|
A
|
A
|
V
|
C
|
A
|
V
|
L
|
140 |
W
|
V
|
L
|
V
|
I
|
G
|
S
|
L
|
V
|
A
|
150 |
R
|
W
|
L
|
L
|
G
|
I
|
Q
|
E
|
G
|
G
|
160 |
ECL2 | |||||||||
F
|
C
|
F
|
R
|
S
|
T
|
R
|
H
|
N
|
F
|
170 |
TM5 | |||||||||
N
|
S
|
M
|
A
|
F
|
P
|
L
|
L
|
G
|
F
|
180 |
Y
|
L
|
P
|
L
|
A
|
V
|
V
|
V
|
F
|
C
|
190 |
S
|
L
|
K
|
V
|
V
|
T
|
A
|
L
|
A
|
Q
|
200 |
ICL3 | TM6 | ||||||||
R
|
P
|
P
|
T
|
D
|
V
|
G
|
Q
|
A
|
E
|
210 |
A
|
T
|
R
|
K
|
A
|
A
|
R
|
M
|
V
|
W
|
220 |
A
|
N
|
L
|
L
|
V
|
F
|
V
|
V
|
C
|
F
|
230 |
L
|
P
|
L
|
H
|
V
|
G
|
L
|
T
|
V
|
R
|
240 |
ECL3 | |||||||||
L
|
A
|
V
|
G
|
W
|
N
|
A
|
C
|
A
|
L
|
250 |
TM7 | |||||||||
L
|
E
|
T
|
I
|
R
|
R
|
A
|
L
|
Y
|
I
|
260 |
T
|
S
|
K
|
L
|
S
|
D
|
A
|
N
|
C
|
C
|
270 |
L
|
D
|
A
|
I
|
C
|
Y
|
Y
|
Y
|
M
|
A
|
280 |
H8 | |||||||||
K
|
E
|
F
|
Q
|
E
|
A
|
S
|
A
|
L
|
A
|
290 |
C-term | |||||||||
V
|
A
|
P
|
S
|
A
|
K
|
A
|
H
|
K
|
S
|
300 |
Q
|
D
|
S
|
L
|
C
|
V
|
T
|
L
|
A
|
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
2-Oleoyllysophosphatydic acid, 2-oleoyl-LPA, kynurenic acid, 1-Lyso-2-oleoyl-phosphatidic acid
STRUCTURE MODELS
STRUCTURES
Found 1 structure(s) - view all details on the Structures page
PDBs: 8H8J